The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS
Abstract
A cell system was developed for the reproducible detection of human T-lymphotropic retroviruses (HTLV family) from patients with the acquired immunodeficiency syndrome (AIDS) or with signs or symptoms that frequently precede AIDS (pre-AIDS). The cells are specific clones from a permissive human neoplastic T-cell line. Some of the clones permanently grow and continuously produce large amounts of virus after infection with cytopathic (HTLV-III) variants of these viruses. One cytopathic effect of HTLV-III in this system is the arrangement of multiple nuclei in a characteristic ring formation in giant cells of the infected T-cell population. These structures can be used as an indicator to detect HTLV-III in clinical specimens. This system opens the way to the routine detection of HTLV-III and related cytopathic variants of HTLV in patients with AIDS or pre-AIDS and in healthy carriers, and it provides large amounts of virus for detailed molecular and immunological analyses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Barré-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vézinet-Brun, F., Rouzioux, C., et al. (1983) · Science · doi:10.1126/science.6189183 · Cited by 7,038
Poiesz, B. J., Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D., & Gallo, R. C. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7415 · Cited by 5,043
Self-citationGallo, R. C., Salahuddin, S. Z., Popovic, M., Shearer, G. M., Kaplan, M., Haynes, B. F., Palker, T. J., Redfield, R., Oleske, J., Safai, B., et al. (1984) · Science · doi:10.1126/science.6200936 · Cited by 3,641
Self-citationMorbidity and Mortality Weekly Report
(2011) · Wilderness & Environmental Medicine · doi:10.1016/j.wem.2010.11.007 · Cited by 3,423
Gottlieb, M. S., Schroff, R., Schanker, H. M., Weisman, J. D., Fan, P. T., Wolf, R. A., & Saxon, A. (1981) · New England Journal of Medicine · doi:10.1056/nejm198112103052401 · Cited by 2,728
Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows
Morgan, D. A., Ruscetti, F. W., & Gallo, R. (1976) · Science · doi:10.1126/science.181845 · Cited by 2,493
Self-citationHinuma, Y., Nagata, K., Hanaoka, M., Nakai, M., Matsumoto, T., Kinoshita, K. I., Shirakawa, S., & Miyoshi, I. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.10.6476 · Cited by 2,252
Yoshida, M., Miyoshi, I., & Hinuma, Y. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.6.2031 · Cited by 2,169
Masur, H., Michelis, M. A., Greene, J. B., Onorato, I., Vande Stouwe, R. A., Holzman, R. S., Wormser, G., Brettman, L., Lange, M., Murray, H. W., et al. (1981) · New England Journal of Medicine · doi:10.1056/nejm198112103052402 · Cited by 1,434
Isolation of Human T-Cell Leukemia Virus in Acquired Immune Deficiency Syndrome (AIDS)
Gallo, R. C., Sarin, P. S., Gelmann, E. P., Robert-Guroff, M., Richardson, E., Kalyanaraman, V. S., Mann, D., Sidhu, G. D., Stahl, R. E., Zolla-Pazner, S., et al. (1983) · Science · doi:10.1126/science.6601823 · Cited by 1,238
Self-citation
Cited by
Items 201–224 of 224
Expression and Characterization of the Trans -Activator of HTLV-III/LAV Virus
Wright, C. M., Felber, B. K., Paskalis, H., & Pavlakis, G. N. (1986) · Science · doi:10.1126/science.3490693 · Cited by 269
Geyer, H., Holschbach, C., Hunsmann, G., & Schneider, J. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37849-9 · Cited by 267
Two species of human CRK cDNA encode proteins with distinct biological activities.
Matsuda, M., Tanaka, S., Nagata, S., Kojima, A., Kurata, T., & Shibuya, M. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.8.3482 · Cited by 267
HIV-1 Reverse Transcriptase Is a Target for Cytotoxic T Lymphocytes in Infected Individuals
Walker, B. D., Flexner, C., Paradis, T. J., Fuller, T. C., Hirsch, M. S., Schooley, R. T., & Moss, B. (1988) · Science · doi:10.1126/science.2451288 · Cited by 267
Gessain, A., Gallo, R. C., & Franchini, G. (1992) · Journal of Virology · doi:10.1128/jvi.66.4.2288-2295.1992 · Cited by 265
Self-citationKanki, P. J., McLane, M. F., King, N. W., Letvin, N. L., Hunt, R. D., Sehgal, P., Daniel, M. D., Desrosiers, R. C., & Essex, M. (1985) · Science · doi:10.1126/science.3873705 · Cited by 265
Immunoglobulin V H 3 Gene Products: Natural Ligands for HIV gp120
Berberian, L., Goodglick, L., Kipps, T. J., & Braun, J. (1993) · Science · doi:10.1126/science.7690497 · Cited by 263
Retrovirus Envelope Glycoproteins
Hunter, E., & Swanstrom, R. (1990) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-75218-6_7 · Cited by 262
Matsukura, M., Zon, G., Shinozuka, K., Robert-Guroff, M., Shimada, T., Stein, C. A., Mitsuya, H., Wong-Staal, F., Cohen, J. S., & Broder, S. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.11.4244 · Cited by 262
Lack of a negative influence on viral growth by the nef gene of human immunodeficiency virus type 1.
Kim, S., Ikeuchi, K., Byrn, R., Groopman, J., & Baltimore, D. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.23.9544 · Cited by 262
Induction of HTLV-III/LAV from a Nonvirus-Producing T-Cell Line: Implications for Latency
Folks, T., Powell, D. M., Lightfoote, M. M., Benn, S., Martin, M. A., & Fauci, A. S. (1986) · Science · doi:10.1126/science.3003906 · Cited by 260
Helseth, E., Kowalski, M., Gabuzda, D., Olshevsky, U., Haseltine, W., & Sodroski, J. (1990) · Journal of Virology · doi:10.1128/jvi.64.5.2416-2420.1990 · Cited by 260
Phosphonylmethoxyethyl purine derivatives, a new class of anti-human immunodeficiency virus agents
Pauwels, R., Balzarini, J., Schols, D., Baba, M., Desmyter, J., Rosenberg, I., Holy, A., & De Clercq, E. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.7.1025 · Cited by 256
Clapham, P. R., Blanc, D., & Weiss, R. A. (1991) · Virology · doi:10.1016/0042-6822(91)90904-p · Cited by 256
Biochemical and immunological analysis of human immunodeficiency virus gag gene products p17 and p24
Veronese, F. D., Copeland, T. D., Oroszlan, S., Gallo, R. C., & Sarngadharan, M. G. (1988) · Journal of Virology · doi:10.1128/jvi.62.3.795-801.1988 · Cited by 203
Self-citationNeuroleukin: A Lymphokine Product of Lectin-Stimulated T Cells
Gurney, M. E., Apatoff, B. R., Spear, G. T., Baumel, M. J., Antel, J. P., Bania, M. B., & Reder, A. T. (1986) · Science · doi:10.1126/science.3020690 · Cited by 195
Yu, H. J., Reuter, M. A., & McDonald, D. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000134 · Cited by 193
Furfine, E. S., & Reardon, J. E. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52449-2 · Cited by 181
Biochemical mechanism of HIV-I Vpr function. Specific interaction with a cellular protein.
Zhao, L. J., Mukherjee, S., & Narayan, O. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40719-8 · Cited by 129
Montefiori, D. C., & Zhou, J. (1991) · Antiviral Research · doi:10.1016/0166-3542(91)90037-r · Cited by 110
Raghavendra, N. K., Shkriabai, N., Graham, R. L., Hess, S., Kvaratskhelia, M., & Wu, L. (2010) · Retrovirology · doi:10.1186/1742-4690-7-66 · Cited by 56
GS-9822, a Preclinical LEDGIN Candidate, Displays a Block-and-Lock Phenotype in Cell Culture
Bruggemans, A., Vansant, G., Balakrishnan, M., Mitchell, M. L., Cai, R., Christ, F., & Debyser, Z. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02328-20 · Cited by 35
Adjuvant Effect of Human Growth Hormone with an Inactivated Flavivirus Vaccine
Stephenson, J. R., Lee, J. M., Bailey, N., Shepherd, A. G., & Melling, J. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/164.1.188 · Cited by 22
Pattishall, K. H. (1993) · The Search for Antiviral Drugs · doi:10.1007/978-1-4899-6718-3_2 · Cited by 6
Metadata
- Authors
- Popovic, M., Sarngadharan, M. G., Read, E., & Gallo, R. C.
- Venue
- Science
- Published
- 1984-05-04
- Volume
- 224
- Issue
- 4648
- Pages
- 497-500
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1991670386
- Cited by
- 3,535
- References
- 29
- FWCI
- 65.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.